Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Musa Yilmaz

Showing results (51-60 of 160) with videos related to

Pageof 16
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|March 24, 2026
Outcomes of Patients Treated With Dasatinib 50 mg/d: A Pooled AnalysisFadi G Haddad, Elias Jabbour, Koji Sasaki, et al.
Cancer|July 29, 2015
Estimated glomerular filtration rate changes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitorsMusa Yilmaz, Amit Lahoti, Susan O'Brien, et al.
Cardiovascular Journal of Africa|May 20, 2016
Adropin as a potential marker of enzyme-positive acute coronary syndromeSuna Aydin, Mehmet Nesimi Eren, Musa Yilmaz, et al.
Leukemia & Lymphoma|December 6, 2023
Acute kidney injury in acute promyelocytic leukemia: a possible adverse effect of high dose arsenic trioxide in obese patientsWei-Ying Jen, Koji Sasaki, Caitlin R Rausch, et al.
American Journal of Hematology|January 6, 2025
Hyper-CVAD and Sequential Blinatumomab Without and With Inotuzumab in Young Adults With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic LeukemiaHagop Kantarjian, Nicholas J Short, Nitin Jain, et al.
Clinical Biochemistry|February 6, 2013
Ghrelins, obestatin, nesfatin-1 and leptin levels in pregnant women with and without hyperemesis gravidarumSami Gungor, Bilgin Gurates, Suleyman Aydin, et al.
Frontiers in Oncology|February 2, 2026
Case Report: FIA plus venetoclax in a patient on hemodialysisJacob E Herstein, Kayleigh R Marx, J Michael Savoy, et al.
Leukemia & Lymphoma|August 19, 2025
Mortality and relapse dynamics in AML after three years of complete remissionSamuel Urrutia, Wei-Ying Jen, Koji Sasaki, et al.
British Journal of Haematology|April 11, 2024
Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expressionWei-Ying Jen, Koji Sasaki, Sanam Loghavi, et al.
Frontiers in Oncology|November 16, 2020
Emergence of <i>BCR</i>-<i>ABL1</i> Fusion in AML Post-FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance - A Case SeriesAhmad S Alotaibi, Musa Yilmaz, Sanam Loghavi, et al.
Pageof 16

Showing results (51-60 of 160) with videos related to

Sort By:
Pageof 16
Clinical Lymphoma, Myeloma & Leukemia|March 24, 2026
Outcomes of Patients Treated With Dasatinib 50 mg/d: A Pooled AnalysisFadi G Haddad, Elias Jabbour, Koji Sasaki, et al.
Cancer|July 29, 2015
Estimated glomerular filtration rate changes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitorsMusa Yilmaz, Amit Lahoti, Susan O'Brien, et al.
Cardiovascular Journal of Africa|May 20, 2016
Adropin as a potential marker of enzyme-positive acute coronary syndromeSuna Aydin, Mehmet Nesimi Eren, Musa Yilmaz, et al.
Leukemia & Lymphoma|December 6, 2023
Acute kidney injury in acute promyelocytic leukemia: a possible adverse effect of high dose arsenic trioxide in obese patientsWei-Ying Jen, Koji Sasaki, Caitlin R Rausch, et al.
American Journal of Hematology|January 6, 2025
Hyper-CVAD and Sequential Blinatumomab Without and With Inotuzumab in Young Adults With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic LeukemiaHagop Kantarjian, Nicholas J Short, Nitin Jain, et al.
Clinical Biochemistry|February 6, 2013
Ghrelins, obestatin, nesfatin-1 and leptin levels in pregnant women with and without hyperemesis gravidarumSami Gungor, Bilgin Gurates, Suleyman Aydin, et al.
Frontiers in Oncology|February 2, 2026
Case Report: FIA plus venetoclax in a patient on hemodialysisJacob E Herstein, Kayleigh R Marx, J Michael Savoy, et al.
Leukemia & Lymphoma|August 19, 2025
Mortality and relapse dynamics in AML after three years of complete remissionSamuel Urrutia, Wei-Ying Jen, Koji Sasaki, et al.
British Journal of Haematology|April 11, 2024
Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expressionWei-Ying Jen, Koji Sasaki, Sanam Loghavi, et al.
Frontiers in Oncology|November 16, 2020
Emergence of <i>BCR</i>-<i>ABL1</i> Fusion in AML Post-FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance - A Case SeriesAhmad S Alotaibi, Musa Yilmaz, Sanam Loghavi, et al.
Pageof 16